Genetica provides low-cost, direct-to-consumer, genetic
testing that utilizes proprietary gene decoding technologies,
all the while putting users in control of their own genetic
data. Operating in the US and Southeast Asia with...
See More a team of
130 people, the company serves 100,000 active users and
has been growing fast since go-to-market in early 2019.
Genetica was founded and seed-funded with the world’s
leading experts in consumer sectors, genetics, artificial
intelligence, and blockchain. The company has developed
patent-pending, low-cost, gene decoding chips and gene
decoding algorithms. Having partnered with global domain
leaders such as Illumina and Thermofisher for genetic
testing, Harvard University for research, and Oasis Labs for
genetic data tokenization, Genetica is looking for
world-leading partners to join our quest in democratizing the
future of health. Genetica proprietary DNA-based genetic
testing and analysis platform intended to provide medicine
and personalized preventative care. The company's platform
offers tests like child development, personalized fitness,
personalized nutrition, heredity cancer screening test,
enabling people to view comprehensive results and
personalized recommendations.